1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population
(
- Contribution to journal › Article
- 2023
-
Mark
Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
(
- Contribution to journal › Article
-
Mark
The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans
(
- Contribution to journal › Article
- 2021
-
Mark
Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity
(
- Contribution to journal › Article
-
Mark
Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort
(
- Contribution to journal › Article
-
Mark
Associations Between Endometriosis and Gut Microbiota
(
- Contribution to journal › Article
- 2020
-
Mark
The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue
(
- Contribution to journal › Article
- 2017
-
Mark
Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - An 11-Year Prospective Study
(
- Contribution to journal › Article
- 2015
-
Mark
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
(
- Contribution to journal › Article
- 2014
-
Mark
A population-based study on the prevalence of NASH using scores validated against liver histology.
(
- Contribution to journal › Article